Capital International Sarl - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital International Sarl ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$3,024,769
-40.6%
72,886
-13.9%
0.14%
-47.1%
Q1 2023$5,093,798
+8.6%
84,699
+32.5%
0.26%
-22.1%
Q4 2022$4,690,072
+12.6%
63,941
+16.6%
0.33%
-1.8%
Q3 2022$4,166,000
-1.4%
54,833
-9.8%
0.34%
-0.9%
Q2 2022$4,226,000
-1.1%
60,802
+17.9%
0.34%
+59.9%
Q1 2022$4,273,000
+22.8%
51,581
+11.3%
0.21%
+27.7%
Q4 2021$3,480,000
+159.3%
46,344
+301.2%
0.17%
+39.5%
Q3 2021$1,342,000
-53.7%
11,552
-11.6%
0.12%
-52.4%
Q2 2021$2,900,000
+105.1%
13,075
+22.2%
0.25%
+85.2%
Q1 2021$1,414,000
-19.6%
10,697
+5.3%
0.14%
-26.6%
Q4 2020$1,758,000
+62.6%
10,157
+4.6%
0.18%
+38.3%
Q3 2020$1,081,000
+139.7%
9,709
+27.6%
0.13%
+121.7%
Q2 2020$451,000
-2.8%
7,608
+10.4%
0.06%
-28.6%
Q1 2020$464,000
-29.4%
6,891
-11.7%
0.08%
-17.6%
Q4 2019$657,0007,8000.10%
Other shareholders
NOVOCURE LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders